{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T09:07:27Z","timestamp":1780304847923,"version":"3.54.0"},"reference-count":79,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001636","name":"University College Cork","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001636","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022542","name":"Breakthrough Cancer Research","doi-asserted-by":"publisher","award":["EPSPG\/2022\/339"],"award-info":[{"award-number":["EPSPG\/2022\/339"]}],"id":[{"id":"10.13039\/501100022542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001592","name":"Higher Education Authority","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001592","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002081","name":"Irish Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002081","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.yexcr.2025.114768","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T03:51:44Z","timestamp":1758685904000},"page":"114768","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Inhibition of USP18 in the presence of IFN-\u03b1 elevates apoptosis, autophagy, and chemosensitivity of oesophageal cancer cell lines"],"prefix":"10.1016","volume":"452","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2313-5218","authenticated-orcid":false,"given":"M.M.","family":"Carey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0282-6888","authenticated-orcid":false,"given":"T.R.","family":"O'Donovan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6764-6274","authenticated-orcid":false,"given":"C.M.","family":"Coveney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0800-8335","authenticated-orcid":false,"given":"S.L.","family":"McKenna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2025.114768_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.612451","article-title":"Mechanisms of pharmaceutical therapy and drug resistance in esophageal cancer","volume":"9","author":"Mao","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.yexcr.2025.114768_bib2","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-074962","article-title":"Advances in diagnosis and management of cancer of the esophagus","volume":"385","author":"Deboever","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.yexcr.2025.114768_bib3","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.48","article-title":"Oesophageal cancer","volume":"3","author":"Smyth","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.yexcr.2025.114768_bib4","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/S0140-6736(17)31462-9","article-title":"Oesophageal cancer","volume":"390","author":"Lagergren","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.yexcr.2025.114768_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.664816","article-title":"Advances in drug resistance of esophageal cancer: from the perspective of tumor microenvironment","volume":"9","author":"Luan","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.yexcr.2025.114768_bib6","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s00018-022-04131-6","article-title":"Molecular mechanisms associated with chemoresistance in esophageal cancer","volume":"79","author":"Lohan-Code\u00e7o","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.yexcr.2025.114768_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.975986","article-title":"Immunotherapy resistance in esophageal cancer: possible mechanisms and clinical implications","volume":"13","author":"Fang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yexcr.2025.114768_bib8","doi-asserted-by":"crossref","first-page":"23479","DOI":"10.18632\/oncotarget.15182","article-title":"UBE2L6\/UBCH8 and ISG15 attenuate autophagy in esophageal cancer cells","volume":"8","author":"Falvey","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.yexcr.2025.114768_bib9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.canlet.2018.09.007","article-title":"ISG15 in cancer: beyond ubiquitin-like protein","volume":"438","author":"Han","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.yexcr.2025.114768_bib10","doi-asserted-by":"crossref","first-page":"538","DOI":"10.3390\/cells11030538","article-title":"ISG15 and ISGylation in human diseases","volume":"11","author":"Mirzalieva","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.yexcr.2025.114768_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/s12276-022-00872-3","article-title":"The diverse repertoire of ISG15: more intricate than initially thought","author":"Kang","year":"2022","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.yexcr.2025.114768_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216080","article-title":"Interferon stimulated gene 15 (ISG15) in cancer: an update","volume":"556","author":"Nguyen","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.yexcr.2025.114768_bib13","doi-asserted-by":"crossref","first-page":"6825","DOI":"10.3390\/ijms21186825","article-title":"Emerging roles of USP18: from biology to pathophysiology","volume":"21","author":"Kang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yexcr.2025.114768_bib14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1089\/jir.2010.0110","article-title":"Interferon-stimulated gene 15 and the protein ISGylation system","volume":"31","author":"Zhang","year":"2011","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.yexcr.2025.114768_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.326","article-title":"Multiple functions of USP18","volume":"7","author":"Honke","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.yexcr.2025.114768_bib16","doi-asserted-by":"crossref","first-page":"9976","DOI":"10.1074\/jbc.M109078200","article-title":"UBP43 (USP18) specifically removes ISG15 from conjugated proteins","volume":"277","author":"Malakhov","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2025.114768_bib17","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1158\/1535-7163.MCT-12-0248","article-title":"Evidence for the ubiquitin protease UBP43 as an antineoplastic target","volume":"11","author":"Guo","year":"2012","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.yexcr.2025.114768_bib18","first-page":"1156","article-title":"USP18 deubiquitinates and stabilizes Twist1 to promote epithelial-mesenchymal transition in glioblastoma cells","volume":"10","author":"Cai","year":"2020","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.yexcr.2025.114768_bib19","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1186\/s12885-020-07241-1","article-title":"USP18 promotes cell proliferation and suppressed apoptosis in cervical cancer cells via activating AKT signaling pathway","volume":"20","author":"Diao","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.yexcr.2025.114768_bib20","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1186\/s12935-020-01442-1","article-title":"USP18 directly regulates Snail1 protein through ubiquitination pathway in colorectal cancer","volume":"20","author":"Huang","year":"2020","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.yexcr.2025.114768_bib21","first-page":"697","article-title":"High expression of USP18 is associated with the growth of colorectal carcinoma","volume":"36","author":"Zhang","year":"2021","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.yexcr.2025.114768_bib22","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3346\/jkms.2014.29.3.351","article-title":"Novel combination markers for predicting survival in patients with muscle invasive bladder cancer: USP18 and DGCR2","volume":"29","author":"Kim","year":"2014","journal-title":"J. Kor. Med. Sci."},{"key":"10.1016\/j.yexcr.2025.114768_bib23","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bbrc.2022.01.020","article-title":"The USP18-FBXO6 axis maintains the malignancy of ovarian cancer","volume":"593","author":"Li","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yexcr.2025.114768_bib24","first-page":"1","article-title":"Large-scale and high-resolution mass spectrometry-based proteomics profiling defines molecular subtypes of esophageal cancer for therapeutic targeting","volume":"12","author":"Liu","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yexcr.2025.114768_bib25","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1053\/j.seminoncol.2014.02.002","article-title":"Interferons and their stimulated genes in the tumor microenvironment","volume":"41","author":"Cheon","year":"2014","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.yexcr.2025.114768_bib26","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/s41573-018-0011-2","article-title":"Interferons \u03b1 and \u03b2 in cancer: therapeutic opportunities from new insights","volume":"18","author":"Borden","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.yexcr.2025.114768_bib27","doi-asserted-by":"crossref","first-page":"833","DOI":"10.2217\/imt-2019-0217","article-title":"Interferons: role in cancer therapy","volume":"12","author":"Abdolvahab","year":"2020","journal-title":"Immunotherapy"},{"key":"10.1016\/j.yexcr.2025.114768_bib28","first-page":"3271","article-title":"5-Fluorouracil up-regulates interferon pathway gene expression in esophageal cancer cells","volume":"25","author":"Matsumura","year":"2005","journal-title":"Anticancer Res."},{"key":"10.1016\/j.yexcr.2025.114768_bib29","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1002\/1097-0142(19950501)75:9<2197::AID-CNCR2820750902>3.0.CO;2-S","article-title":"A phase II trial of interferon alpha-2A, 5-fluorouracil, and cisplatin in patients with advanced esophageal carcinoma","volume":"75","author":"Ilson","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.yexcr.2025.114768_bib30","first-page":"389","article-title":"Versatility of USP18 in physiology and pathophysiology","volume":"66","author":"Dziama\u0142ek-Macioszczyk","year":"2019","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.yexcr.2025.114768_bib31","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41416-020-01167-y","article-title":"Deletion of the deISGylating enzyme USP18 enhances tumour cell antigenicity and radiosensitivity","volume":"124","author":"Pinto-Fernandez","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.yexcr.2025.114768_bib32","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1158\/0008-5472.CAN-09-1942","article-title":"Identification of USP18 as an important regulator of the susceptibility to IFN-\u03b1 and drug-induced apoptosis","volume":"70","author":"Potu","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2025.114768_bib33","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s10495-011-0639-4","article-title":"Type I IFNs signaling and apoptosis resistance in glioblastoma cells","volume":"16","author":"Sgorbissa","year":"2011","journal-title":"Apoptosis"},{"key":"10.1016\/j.yexcr.2025.114768_bib34","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41467-022-35348-5","article-title":"Expansion of interferon inducible gene pool via USP18 inhibition promotes cancer cell pyroptosis","volume":"14","author":"Arimoto","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yexcr.2025.114768_bib35","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1091\/mbc.e08-08-0880","article-title":"RNA interference screen identifies Usp18 as a regulator of epidermal growth factor receptor synthesis","volume":"20","author":"Duex","year":"2009","journal-title":"MBoC"},{"key":"10.1016\/j.yexcr.2025.114768_bib36","doi-asserted-by":"crossref","first-page":"25377","DOI":"10.1074\/jbc.M111.222760","article-title":"Usp18 regulates epidermal growth factor (EGF) receptor expression and cancer cell survival via MicroRNA-7","volume":"286","author":"Duex","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2025.114768_bib37","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1158\/1541-7786.MCR-16-0369","article-title":"Deubiquitinase USP18 loss mislocalizes and destabilizes KRAS in lung cancer","volume":"15","author":"Mustachio","year":"2017","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.yexcr.2025.114768_bib38","doi-asserted-by":"crossref","first-page":"9875","DOI":"10.1158\/0008-5472.CAN-10-1100","article-title":"Blockade of the ubiquitin protease UBP43 destabilizes transcription factor PML\/RAR\u03b1 and inhibits the growth of acute promyelocytic leukemia","volume":"70","author":"Guo","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2025.114768_bib39","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/15384047.2022.2054242","article-title":"Loss of ubiquitin-specific peptidase 18 destabilizes 14-3-3\u03b6 protein and represses lung cancer metastasis","volume":"23","author":"Chen","year":"2022","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.yexcr.2025.114768_bib40","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/1476-4598-13-132","article-title":"USP18 is crucial for IFN-\u03b3-mediated inhibition of B16 melanoma tumorigenesis and antitumor immunity","volume":"13","author":"Hong","year":"2014","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.yexcr.2025.114768_bib41","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1186\/s12885-015-1883-8","article-title":"Mice null for the deubiquitinase USP18 spontaneously develop leiomyosarcomas","volume":"15","author":"Chinyengetere","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.yexcr.2025.114768_bib42","author":"Jov\u00e9","year":"2023","journal-title":"Human USP18 protects diverse cancer lineages from Type I Interferon independently of its canonical catalytic function"},{"key":"10.1016\/j.yexcr.2025.114768_bib43","doi-asserted-by":"crossref","DOI":"10.1042\/BCJ20230301","article-title":"ISGylation-independent protection of cell growth by USP18 following interferon stimulation","author":"Clancy","year":"2023","journal-title":"Biochem. J."},{"key":"10.1016\/j.yexcr.2025.114768_bib44","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nsmb.3378","article-title":"STAT2 is an essential adaptor in USP18-mediated suppression of type I interferon signaling","volume":"24","author":"Arimoto","year":"2017","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.yexcr.2025.114768_bib45","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1038\/sj.emboj.7601149","article-title":"UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity","volume":"25","author":"Malakhova","year":"2006","journal-title":"EMBO J."},{"key":"10.1016\/j.yexcr.2025.114768_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2021.112884","article-title":"USP18 promotes tumor metastasis in esophageal squamous cell carcinomas via deubiquitinating ZEB1","volume":"409","author":"Song","year":"2021","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.yexcr.2025.114768_bib47","doi-asserted-by":"crossref","DOI":"10.1111\/1759-7714.70013","article-title":"HOXA5 derives the malignant progression and cisplatin resistance of esophageal squamous cell carcinoma by regulating USP18-mediated IFI27 deubiquitination","volume":"16","author":"Wang","year":"2025","journal-title":"Thorac. Cancer"},{"key":"10.1016\/j.yexcr.2025.114768_bib48","doi-asserted-by":"crossref","first-page":"509","DOI":"10.4161\/auto.7.5.15066","article-title":"Induction of autophagy by drug-resistant esophageal cancer cells promotes their survival and recovery following treatment with chemotherapeutics","volume":"7","author":"O'Donovan","year":"2011","journal-title":"Autophagy"},{"key":"10.1016\/j.yexcr.2025.114768_bib49","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70173","article-title":"Expression of MxA in esophageal cancer cell lines can influence sensitivity to chemotherapeutic agents but this does not require apoptosis","volume":"13","author":"Hayes","year":"2024","journal-title":"Cancer Med."},{"key":"10.1016\/j.yexcr.2025.114768_bib50","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/(SICI)1097-0215(19960126)65:3<372::AID-IJC16>3.0.CO;2-C","article-title":"Characterization of p53 gene mutations in esophageal squamous cell carcinoma cell lines: increased frequency and different spectrum of mutations from primary tumors","volume":"65","author":"Tanaka","year":"1996","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.yexcr.2025.114768_bib51","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/humu.22556","article-title":"Analysis of TP53 mutation status in human cancer cell lines: a reassessment","volume":"35","author":"Leroy","year":"2014","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.yexcr.2025.114768_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-022-05408-1","article-title":"Mutant p53 in cancer: from molecular mechanism to therapeutic modulation","volume":"13","author":"Chen","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.yexcr.2025.114768_bib53","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.trecan.2022.09.003","article-title":"How cancer cells make and respond to interferon-I","volume":"9","author":"Cheon","year":"2023","journal-title":"Trends Cancer"},{"key":"10.1016\/j.yexcr.2025.114768_bib54","article-title":"The curious case of type I interferon signaling in cancer","volume":"1879","author":"Chhipa","year":"2024","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.yexcr.2025.114768_bib55","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1479-5876-11-73","article-title":"A three-gene signature as potential predictive biomarker for irinotecan sensitivity in gastric cancer","volume":"11","author":"Shen","year":"2013","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.yexcr.2025.114768_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2020.118647","article-title":"ISG15 suppresses translation of ABCC2 via ISGylation of hnRNPA2B1 and enhances drug sensitivity in cisplatin resistant ovarian cancer cells","volume":"1867","author":"Wang","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.yexcr.2025.114768_bib57","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1158\/1535-7163.MCT-07-2345","article-title":"ISG15 as a novel tumor biomarker for drug sensitivity","volume":"7","author":"Desai","year":"2008","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.yexcr.2025.114768_bib58","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1172\/JCI61762","article-title":"Chemosensitivity is controlled by p63 modification with ubiquitin-like protein ISG15","volume":"122","author":"Jeon","year":"2012","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.yexcr.2025.114768_bib59","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3892\/ol.2022.13355","article-title":"Interferon-\u03b1 and its effects on cancer cell apoptosis","volume":"24","author":"Shi","year":"2022","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.yexcr.2025.114768_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.720765","article-title":"Proteomics mapping of the ISGylation landscape in innate immunity","volume":"12","author":"Thery","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yexcr.2025.114768_bib61","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1242\/jcs.205468","article-title":"ISGylation \u2013 a key to lock the cell gates for preventing the spread of threats","volume":"130","author":"Villarroya-Beltri","year":"2017","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.yexcr.2025.114768_bib62","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1158\/0008-5472.CAN-05-1123","article-title":"Elevated expression of ISG15 in tumor cells interferes with the ubiquitin\/26S proteasome pathway","volume":"66","author":"Desai","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2025.114768_bib63","article-title":"ISGylation in innate antiviral immunity and pathogen defense responses: a review","volume":"9","author":"Zhang","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.yexcr.2025.114768_bib64","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1158\/1535-7163.MCT-08-0753","article-title":"UBE1L causes lung cancer growth suppression by targeting cyclin D1","volume":"7","author":"Feng","year":"2008","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.yexcr.2025.114768_bib65","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/onc.2012.633","article-title":"ISGylation governs the oncogenic function of Ki-Ras in breast cancer","volume":"33","author":"Burks","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.yexcr.2025.114768_bib66","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.4161\/cc.29209","article-title":"Isg15 controls p53 stability and functions","volume":"13","author":"Huang","year":"2014","journal-title":"Cell Cycle"},{"key":"10.1016\/j.yexcr.2025.114768_bib67","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1128\/MCB.26.2.472-479.2006","article-title":"Ube1L and protein ISGylation are not essential for alpha\/beta interferon signaling","volume":"26","author":"Kim","year":"2006","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.yexcr.2025.114768_bib68","first-page":"380","volume":"7","author":"Wang","year":"2024"},{"key":"10.1016\/j.yexcr.2025.114768_bib69","doi-asserted-by":"crossref","DOI":"10.1177\/00220345241305590","article-title":"Tumor-intrinsic SIRPA drives pyroptosis evasion in head and neck cancer","author":"Song","year":"2025","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.yexcr.2025.114768_bib70","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nrm2239","article-title":"Self-eating and self-killing: crosstalk between autophagy and apoptosis","volume":"8","author":"Maiuri","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.yexcr.2025.114768_bib71","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.bbrc.2022.02.048","article-title":"USP18 reduces paclitaxol sensitivity of triple-negative breast cancer via autophagy","volume":"599","author":"Ge","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yexcr.2025.114768_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110617","article-title":"USP18 enhances the resistance of BRAF-mutated melanoma cells to vemurafenib by stabilizing cGAS expression to induce cell autophagy","volume":"122","author":"Ma","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.yexcr.2025.114768_bib73","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1080\/15548627.2015.1023982","article-title":"Modification of BECN1 by ISG15 plays a crucial role in autophagy regulation by type I IFN\/interferon","volume":"11","author":"Xu","year":"2015","journal-title":"Autophagy"},{"key":"10.1016\/j.yexcr.2025.114768_bib74","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1074\/jbc.M114.593871","article-title":"Interferon-stimulated gene 15 (ISG15) and ISG15-linked proteins can associate with members of the selective autophagic process, histone deacetylase 6 (HDAC6) and SQSTM1\/p62","volume":"290","author":"Nakashima","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2025.114768_bib75","doi-asserted-by":"crossref","DOI":"10.7150\/ijbs.85424","article-title":"ISG15 promotes progression and gemcitabine resistance of pancreatic cancer cells through ATG7","volume":"20","author":"Meng","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.yexcr.2025.114768_bib76","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1158\/0008-5472.CAN-17-1752","article-title":"Evidence for the ISG15-specific deubiquitinase USP18 as an antineoplastic target","volume":"78","author":"Mustachio","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2025.114768_bib77","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1084\/jem.20151529","article-title":"Human USP18 deficiency underlies type 1 interferonopathy leading to severe pseudo-TORCH syndrome","volume":"213","author":"Meuwissen","year":"2016","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.yexcr.2025.114768_bib78","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20211273","article-title":"A partial form of inherited human USP18 deficiency underlies infection and inflammation","volume":"219","author":"Martin-Fernandez","year":"2022","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.yexcr.2025.114768_bib79","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20192319","article-title":"Homozygous STAT2 gain-of-function mutation by loss of USP18 activity in a patient with type I interferonopathy","volume":"217","author":"Gruber","year":"2020","journal-title":"J. Exp. Med."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482725003684?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482725003684?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T08:34:19Z","timestamp":1780302859000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482725003684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":79,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0014482725003684"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2025.114768","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of USP18 in the presence of IFN-\u03b1 elevates apoptosis, autophagy, and chemosensitivity of oesophageal cancer cell lines","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2025.114768","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"114768"}}